Mycobacterium tuberculosis: A model system for structural genomics

Current Opinion in Structural Biology

Volumn 13, Issue 6, 2003, Pages 658-664

  Smith, Clare V ^a   Sacchettini, James C ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARRIER PROTEIN; CYTOCHROME P450 ISOENZYME; FATTY ACID SYNTHASE; FLUCONAZOLE; ISONIAZID; MYCOLIC ACID; PANTOTHENIC ACID;

ALPHA HELIX; AUXOTROPHY; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CLINICAL RESEARCH; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME SUBUNIT; FATTY ACID SYNTHESIS; GENOMICS; HOST PATHOGEN INTERACTION; INTRACELLULAR MEMBRANE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TRYPANOSOMA BRUCEI;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 0347481469     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2003.10.004     Document Type: Review

References (50)

1. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry C.E. IIIet al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 393:1998;537-544.
2. Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O., Peterson J., DeBoy R., Dodson R., Gwinn M., Haft D.et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 184:2002;5479-5490.
3. Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., Wheeler P.R., Honore N., Garnier T., Churcher C., Harris D.et al. Massive gene decay in the leprosy bacillus. Nature. 409:2001;1007-1011.
4. Garnier T., Eiglmeier K., Camus J.-C., Medina N., Mansoor H., Pryor M., Duthoy S., Grondin S., Lacroix C., Monsempe C.et al. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. USA. 100:2003;7877-7882.
5. Betts J.C., Dodson P., Quan S., Lewis A.P., Thomas P.J., Duncan K., McAdam R.A. Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551. Microbiology. 146:2000;3205-3216.
6. Jungblut P.R., Muller E.-C., Mattow J., Kaufmann S.H.E. Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv not predicted by genomics. Infect. Immun. 69:2001;5905-5907.
7. Betts J.C., Lukey P.T., Robb L.C., McAdam R.A., Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:2002;717-731.
8. Goulding C.W., Apostol M., Anderson D.H., Gill H.S., Smith C.V., Kuo M.R., Yang J.K., Waldo G.S., Suh S.W., Chauhan R.et al. The TB structural genomics consortium: providing a structural foundation for drug discovery. Curr. Drug. Targets. Infect. Disord. 2:2002;121-141 This paper presents an overview of the TB Structural Genomics Consortium ( http://doe-mbi.ucla.edu/TB ), with contributions from member labs describing target selection and progress.
9. Rupp B. High-throughput crystallography at an affordable cost: the TB Structural Genomics Consortium Crystallization Facility. Acc. Chem. Res. 36:2003;173-181 This review describes the high-throughput crystallization methods developed and used by the TB Structural Genomics Consortium crystallization facility.
10. Dessen A., Quemard A., Blanchard J.S., Jacobs W.R. Jr., Sacchettini J.C. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science. 267:1995;1638-1641.
11. Kuo M.R., Morbidoni H.R., Alland D., Sneddon S.F., Gourlie B.B., Staveski M.M., Leonard M., Gregory J.S., Janjigian A.D., Yee C.et al. Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data. J. Biol. Chem. 278:2003;20851-20859 A description of complex structures comprising InhA and novel inhibitors, demonstrating the potential for structure-based drug discovery.
12. Scarsdale J.N., Kazanina G., He X., Reynolds K.A., Wright H.T. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III. J. Biol. Chem. 276:2001;20516-20522.
13. Cohen-Gonsaud M., Ducasse S., Hoh F., Zerbib D., Labesse G., Quemard A. Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis. J. Mol. Biol. 320:2002;249-261.
14. Huang C.-c., Smith C.V., Glickman M.S., Jacobs W.R. Jr., Sacchettini J.C. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis. J. Biol. Chem. 277:2002;11559-11569.
15. Barry C.E. III, Lee R.E., Mdluli K., Sampson A.E., Schroeder B.G., Slayden R.A., Yuan Y. Mycolic acids: structure, biosynthesis and physiological function. Prog. Lipid. Res. 37:1998;143-179.
16. Sambandamurthy V.K., Wang X., Chen B., Russell R.G., Derrick S., Collins F.M., Morris S.L., Jacobs W.R. Jr. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat. Med. 8:2002;1171-1174.
17. Wang S., Eisenberg D. Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate. Protein Sci. 12:2003;1097-1108 A comprehensive study of PanC, enabling insights into the mechanism and providing a structural basis for inhibitor development.
18. Smith D.A., Parish T., Stoker N.G., Bancroft G.J. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect. Immun. 69:2001;1142-1150.
19. Gokulan K., Rupp B., Pavelka M.S. Jr., Jacobs W.R. Jr., Sacchettini J.C. Crystal structure of Mycobacterium tuberculosis diaminopimelate decarboxylase, an essential enzyme in bacterial lysine biosynthesis. J. Biol. Chem. 278:2003;18588-18596.
20. Jackson L.K., Brooks H.B., Osterman A.L., Goldsmith E.J., Phillips M.A. Altering the reaction specificity of eukaryotic ornithine decarboxylase. Biochemistry. 39:2000;11247-11257.
21. Kern A.D., Oliveira M.A., Coffino P., Hackert M.L. Structure of mammalian ornithine decarboxylase at 1.6. Å resolution: stereochemical implications of PLP-dependent amino acid decarboxylases Structure Fold Des. 7:1999;567-581.
22. Almrud J.J., Oliveira M.A., Kern A.D., Grishin N.V., Phillips M.A., Hackert M.L. Crystal structure of human ornithine decarboxylase at 2.1. Å resolution: structural insights to antizyme binding J. Mol. Biol. 295:2000;7-16.
23. Grishin N.V., Osterman A.L., Brooks H.B., Phillips M.A., Goldsmith E.J. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. Biochemistry. 38:1999;15174-15184.
24. McLean K.J., Marshall K.R., Richmond A., Hunter I.S., Fowler K., Kieser T., Gurcha S.S., Besra G.S., Munro A.W. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology. 148:2002;2937-2949.
25. Podust L.M., Poulos T.L., Waterman M.R. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. USA. 98:2001;3068-3073.
26. Leys D., Mowat C.G., McLean K.J., Richmond A., Chapman S.K., Walkinshaw M.D., Munro A.W. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06. Å reveals novel features of cytochrome P450 J. Biol. Chem. 278:2003;5141-5147 A comparison of CYP121 with other cytochrome structures reveals interesting features of the active site architecture.
27. Horwitz M., Lee B., Dillon B., Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 92:1995;1530-1534.
28. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 276:1997;1420-1422.
29. Ronning D.R., Klabunde T., Besra G.S., Vissa V.D., Belisle J.T., Sacchettini J.C. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat. Struct. Biol. 7:2000;141-146.
30. Anderson D.H., Harth G., Horwitz M.A., Eisenberg D. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30. kDa major secretory protein (antigen 85B), a mycolyl transferase J. Mol. Biol. 307:2001;671-681.
31. Manca C., Lyashchenko K., Wiker H.G., Usai D., Colangeli R., Gennaro M.L. Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 65:1997;16-23.
32. Goulding C.W., Parseghian A., Sawaya M.R., Cascio D., Apostol M.I., Gennaro M.L., Eisenberg D. Crystal structure of a major secreted protein of Mycobacterium tuberculosis-MPT63 at 1.5-Å resolution. Protein Sci. 11:2002;2887-2893 MPT63 is a mycobacteria-specific protein, proposed to be important in virulence, with an antiparallel β-sandwich immunoglobulin fold. Structure analysis suggests a possible function in host-pathogen interactions.
33. Owen D.J., Vallis Y., Pearse B.M.F., McMahon H.T., Evans P.R. The structure and function of the {beta}2-adaptin appendage domain. EMBO J. 19:2000;4216-4227.
34. Hamburger Z.A., Brown M.S., Isberg R.R., Bjorkman P.J. Crystal structure of invasin: a bacterial integrin-binding protein. Science. 286:1999;291-295.
35. Taylor A.B., Benglis D.M. Jr., Dhandayuthapani S., Hart P.J. Structure of Mycobacterium tuberculosis methionine sulfoxide reductase A in complex with protein-bound methionine. J. Bacteriol. 185:2003;4119-4126 The mechanistic differences between peptide methionine sulfoxide reductases are revealed by comparison of the TB MsrA structure with the E. coli and B. taurus MsrAs.
36. Tete-Favier F., Cobessi D., Boschi-Muller S., Azza S., Branlant G., Aubry A. Crystal structure of the Escherichia coli peptide methionine sulphoxide reductase at 1.9. Å resolution Structure Fold Des. 8:2000;1167-1178.
37. Lowther W.T., Brot N., Weissbach H., Matthews B.W. Structure and mechanism of peptide methionine sulfoxide reductase, an 'anti-oxidation' enzyme. Biochemistry. 39:2000;13307-13312.
38. Mallick P., Goodwill K.E., Fitz-Gibbon S., Miller J.H., Eisenberg D. Selecting protein targets for structural genomics of Pyrobaculum aerophilum: validating automated fold assignment methods by using binary hypothesis testing. Proc. Natl. Acad. Sci. USA. 97:2000;2450-2455.
39. Scapin G., Ozturk D.H., Grubmeyer C., Sacchettini J.C. The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and alpha-D-5-phosphoribosyl-1-pyrophosphate. Biochemistry. 34:1995;10744-10754.
40. Eads J.C., Ozturk D., Wexler T.B., Grubmeyer C., Sacchettini J.C. A new function for a common fold: the crystal structure of quinolinic acid phosphoribosyltransferase. Structure. 5:1997;47-58.
41. Cho Y., Sharma V., Sacchettini J.C. Crystal structure of ATP phosphoribosyltransferase from Mycobacterium tuberculosis. J. Biol. Chem. 278:2003;8333-8339.
42. Sharma V., Arockiasamy A., Ronning D.R., Savva C.G., Holzenburg A., Braunstein M., Jacobs W.R. Jr., Sacchettini J.C. Crystal structure of Mycobacterium tuberculosis SecA, a preprotein translocating ATPase. Proc. Natl. Acad. Sci. USA. 100:2003;2243-2248.
43. Subramanya H.S., Bird L.E., Brannigan J.A., Wigley D.B. Crystal structure of a DExx box DNA helicase. Nature. 384:1996;379-383.
44. Johnston J.M., Arcus V.L., Morton C.J., Parker M.W., Baker E.N. Crystal structure of a putative methyltransferase from Mycobacterium tuberculosis: misannotation of a genome clarified by protein structural analysis. J. Bacteriol. 185:2003;4057-4065 An interesting example of the re-assignment of function based on structure.
45. Herzberg O., Chen C.C.H., Kapadia G., McGuire M., Carroll L.J., Noh S.J., Dunaway-Mariano D. Swiveling-domain mechanism for enzymatic phosphotransfer between remote reaction sites. Proc. Natl. Acad. Sci. USA. 93:1996;2652-2657.
46. Martin J.L., McMillan F.M. SAM (dependent) I AM: the S- adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 12:2002;783-793.
47. Trievel R.C., Beach B.M., Dirk L.M., Houtz R.L., Hurley J.H. Structure and catalytic mechanism of a SET domain protein methyltransferase. Cell. 111:2002;91-103.
48. Yeates T.O. Structures of SET domain proteins: protein lysine methyltransferases make their mark. Cell. 111:2002;5-7.
49. Editorial comment: Taming tuberculosis - again. Nat Struct Biol 2000, 7:87-88.
50. Goulding C.W., Perry L.J. Protein production in Escherichia coli for structural studies by X-ray crystallography. J. Struct. Biol. 142:2003;133-143.